News
This Simple Dietary Switch Could Be a Game-Changer for Women With Diabetes, Endocrinologists Say first appeared on Parade on ...
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...
Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...
The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...
7d
Clinical Trials Arena on MSNVertex presents data from Phase I/II stage of trial for type 1 diabetesThe safety profile of the therapy was found to be favourable, without any serious adverse events linked to the treatment.
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
3d
HealthDay on MSNADA: Insulin Efsitora Noninferior to Glargine for Reducing HbA1c in Adults With Type 2 DiabetesOnce-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results